Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-04 4:45 pm Sale | 2025-12-31 | 13G | INNATE PHARMA S A SPONSORED AD IPHA | NOVO NORDISK A S | 7,333,778 7.820% | -1,561,871 (-17.56%) | Filing History |
| 2026-02-06 09:48 am Purchase | 2025-12-22 | 13D | INNATE PHARMA S A SPONSORED AD IPHA | ASTRAZENECA PLC AZN | 7,825,501 8.300% | 340,001 (+4.54%) | Filing History |
| 2025-10-21 08:00 am Sale | 2025-07-14 | 13G | INNATE PHARMA S A SPONSORED AD IPHA | NOVO NORDISK A S | 8,895,649 9.650% | -921,897 (-9.39%) | Filing History |
| 2025-05-07 4:02 pm Purchase | 2025-04-25 | 13D | INNATE PHARMA S A SPONSORED AD IPHA | Bpifrance Participations SA | 7,319,429 7.900% | 132,801 (+1.85%) | Filing History |
| 2025-04-29 6:48 pm Unchanged | 2025-04-23 | 13G | INNATE PHARMA S A SPONSORED AD IPHA | Sanofi | 8,345,387 9.050% | 0 (Unchanged) | Filing History |
| 2025-04-29 2:08 pm Purchase | 2025-04-23 | 13G | INNATE PHARMA S A SPONSORED AD IPHA | Sanofi | 8,345,387 9.050% | 8,345,387 (New Position) | Filing History |
| 2022-12-06 11:52 am Sale | 2022-11-23 | 13D | INNATE PHARMA S A SPONSORED AD IPHA | Bpifrance Participations SA | 7,186,628 9.000% | -801,741 (-10.04%) | Filing History |
| 2022-10-21 12:58 pm Sale | 2022-10-11 | 13D | INNATE PHARMA S A SPONSORED AD IPHA | Bpifrance Participations SA | 7,988,369 10.000% | -964,098 (-10.77%) | Filing History |